ES417377A1 - Un procedimiento para preparar tri-ptoluensulfonato de s- adenosil-l-metionina. - Google Patents
Un procedimiento para preparar tri-ptoluensulfonato de s- adenosil-l-metionina.Info
- Publication number
- ES417377A1 ES417377A1 ES417377A ES417377A ES417377A1 ES 417377 A1 ES417377 A1 ES 417377A1 ES 417377 A ES417377 A ES 417377A ES 417377 A ES417377 A ES 417377A ES 417377 A1 ES417377 A1 ES 417377A1
- Authority
- ES
- Spain
- Prior art keywords
- adenosil
- methionine
- salt
- preparation
- protids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229960004452 methionine Drugs 0.000 title abstract 3
- 150000003839 salts Chemical class 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 150000003943 catecholamines Chemical class 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 230000004060 metabolic process Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/38—Nucleosides
- C12P19/40—Nucleosides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same ring, e.g. purine nucleosides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Microbiology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- General Engineering & Computer Science (AREA)
- Obesity (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2779372 | 1972-08-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES417377A1 true ES417377A1 (es) | 1976-02-16 |
Family
ID=11222342
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES417377A Expired ES417377A1 (es) | 1972-08-02 | 1973-07-30 | Un procedimiento para preparar tri-ptoluensulfonato de s- adenosil-l-metionina. |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US3893999A (es) |
| JP (1) | JPS5235726B2 (es) |
| AR (1) | AR195350A1 (es) |
| AT (1) | AT341684B (es) |
| AU (1) | AU474015B2 (es) |
| BE (1) | BE802981A (es) |
| CA (1) | CA1006872A (es) |
| CH (1) | CH592112A5 (es) |
| CS (1) | CS195254B2 (es) |
| DD (1) | DD107461A5 (es) |
| DE (1) | DE2336401C3 (es) |
| DK (1) | DK131868C (es) |
| ES (1) | ES417377A1 (es) |
| FI (1) | FI52466C (es) |
| FR (1) | FR2194425B1 (es) |
| GB (1) | GB1425384A (es) |
| HK (1) | HK31580A (es) |
| HU (1) | HU167266B (es) |
| IE (1) | IE37913B1 (es) |
| IL (1) | IL42764A (es) |
| MX (1) | MX4544E (es) |
| NL (1) | NL152864B (es) |
| NO (1) | NO137941C (es) |
| PL (1) | PL87381B1 (es) |
| RO (1) | RO63451A (es) |
| SE (1) | SE400085B (es) |
| SU (1) | SU646915A3 (es) |
| YU (1) | YU36037B (es) |
| ZA (1) | ZA734876B (es) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE39517B1 (en) * | 1973-06-27 | 1978-10-25 | Bioresearch Sas | Double salts of s-adenosyl-l-methhionine |
| AR221676A1 (es) * | 1974-07-12 | 1981-03-13 | Bioresearch Sas | Procedimiento para la preparacion de sales estables sulfonicas y/o sulfuricas de la s-adenosil-l-metionina,particularmente utiles como donadores especificos de metilo para las reacciones bioquimicas de transferencia del grupo ch3;asi como tambien las reacciones fundamentales en el metabolismo lipilico,protilico y glucidico |
| US4109079A (en) * | 1975-10-16 | 1978-08-22 | Yamasa Shoyu Kabushiki Kaisha | Stabilized s-adenosyl-l-methionine preparations |
| GB2064523B (en) * | 1979-12-04 | 1983-06-29 | Kanegafuchi Chemical Ind | Stable composition of s-adenosyl-l-methionine |
| IT1137640B (it) | 1981-08-24 | 1986-09-10 | Bioresearch Srl | Sali stabili della s-adenosilmetionina,processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo |
| IT1137892B (it) * | 1981-08-24 | 1986-09-10 | Bioresearch Srl | Sali stabili della s-adenosilmetionina,processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo |
| IT1139974B (it) * | 1981-09-11 | 1986-09-24 | Bioresearch Srl | Derivati della s-adenosilmetionina,processo per la preparazione e composizioni terapeutiche che li contengono come principio attivo |
| IT1169773B (it) * | 1983-08-24 | 1987-06-03 | Bioresearch Spa | Processo per la produzione di sali stabili della solfo-adenosil-l-metionina |
| IT1169774B (it) * | 1983-08-24 | 1987-06-03 | Bioresearch Spa | Composizioni terapeutiche iniettabili contenenti sali stabili della s-adenosil-l-metionina |
| IT1173992B (it) * | 1984-05-16 | 1987-06-24 | Bioresearch Spa | Sali stabili della solfo-adenosil-l-metionina (same) particolarmente idonei per uso farmaceutico orale |
| IT1173990B (it) * | 1984-05-16 | 1987-06-24 | Bioresearch Spa | Sali stabili della solfo-adenosil-l-metionina (same) particolarmente adatti per uso parenterale |
| IT1200589B (it) * | 1985-02-14 | 1989-01-27 | Gibipharma Spa | Derivati naturali attivita farmagologica |
| AU2538588A (en) * | 1987-10-09 | 1989-05-02 | Mario De Rosa | Lipophilic salts of s-adenosyl-l-methionine (sam) with acylated taurine derivatives |
| DE19515275A1 (de) * | 1995-04-26 | 1996-10-31 | Knoll Ag | Neue Verwendung von (S)-Adenosyl-L-methionin(SAMe) |
| US6759395B2 (en) | 2000-12-18 | 2004-07-06 | Orchid Chemicals & Pharmaceuticals, Ltd. | Soft-gelatin capsule comprising S-adenosylmethionine and a method for producing the same |
| US8063024B2 (en) * | 2005-01-26 | 2011-11-22 | University Of Manitoba | Use of S-adenosylmethionine, vitamin E, and vitamin C for the treatment of oxidative liver injury and insulin resistance |
| US20090012036A1 (en) * | 2005-05-24 | 2009-01-08 | Hebert Rolland F | Stable S-adenosyl-L-methionine |
| ITMI20060629A1 (it) | 2006-03-31 | 2007-10-01 | Daniele Giovannone | Composizioni solide orali a base di s-adenosilmetionina e processo per il loro ottenimento |
| CA2677053C (en) * | 2007-01-31 | 2016-03-15 | Methylation Sciences International Srl | Extended release pharmaceutical formulations of s-adenosylmethionine |
| US20090088404A1 (en) * | 2007-01-31 | 2009-04-02 | Methylation Sciences International Srl | Extended Release Pharmaceutical Formulations of S-Adenosylmethionine |
| US20090197824A1 (en) * | 2008-01-31 | 2009-08-06 | Methylation Sciences International Srl | Extended Release Pharmaceutical Formulations of S-Adenosylmethionine |
| ITMI20071374A1 (it) * | 2007-07-10 | 2009-01-11 | Gnosis Spa | Sali stabili di s-adenosilmetionina e processo per il loro ottenimento. |
| US20100004191A1 (en) * | 2008-07-01 | 2010-01-07 | Rolland F Hebert | Compositions of S-adenosyl-L-methionine. |
| US8329208B2 (en) | 2009-07-28 | 2012-12-11 | Methylation Sciences International Srl | Pharmacokinetics of S-adenosylmethionine formulations |
| US20110027342A1 (en) * | 2009-07-28 | 2011-02-03 | Msi Methylation Sciences, Inc. | S-adenosylmethionine formulations with enhanced bioavailability |
| EP2696879A4 (en) | 2011-04-15 | 2014-11-26 | Scimar Ltd | USE OF S-ADENOSYLMETHIONINE, VITAMIN E AND VITAMIN C IN THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DYSFUNCTION |
| CN106074589A (zh) | 2012-10-17 | 2016-11-09 | 甲基化物科学国际有限公司 | 包含s‑腺苷甲硫氨酸及没食子酸酯的组合物 |
| EP2945959B1 (en) | 2013-01-16 | 2020-05-13 | Hebert Sam-E LLC | Stable indole-3-propionate salts of s-adenosyl-l-methionine |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2946781A (en) * | 1957-02-06 | 1960-07-26 | Merck & Co Inc | Process for the preparation of adenosyl homocysteine |
| US3642772A (en) * | 1968-09-04 | 1972-02-15 | Boehringer Mannheim Gmbh | Process for preparing s-adenosyl homocysteine |
-
1973
- 1973-07-16 IE IE1192/73A patent/IE37913B1/xx unknown
- 1973-07-17 IL IL42764A patent/IL42764A/en unknown
- 1973-07-17 US US380097A patent/US3893999A/en not_active Expired - Lifetime
- 1973-07-17 DE DE2336401A patent/DE2336401C3/de not_active Expired
- 1973-07-17 ZA ZA734876A patent/ZA734876B/xx unknown
- 1973-07-19 FR FR7326500A patent/FR2194425B1/fr not_active Expired
- 1973-07-19 GB GB3449973A patent/GB1425384A/en not_active Expired
- 1973-07-25 RO RO7300075582A patent/RO63451A/ro unknown
- 1973-07-26 CS CS735374A patent/CS195254B2/cs unknown
- 1973-07-26 YU YU2030/73A patent/YU36037B/xx unknown
- 1973-07-27 AT AT664173A patent/AT341684B/de not_active IP Right Cessation
- 1973-07-27 CA CA177,689A patent/CA1006872A/en not_active Expired
- 1973-07-27 AR AR249310A patent/AR195350A1/es active
- 1973-07-30 AU AU58680/73A patent/AU474015B2/en not_active Expired
- 1973-07-30 BE BE134028A patent/BE802981A/xx not_active IP Right Cessation
- 1973-07-30 ES ES417377A patent/ES417377A1/es not_active Expired
- 1973-08-01 SE SE7310587A patent/SE400085B/xx unknown
- 1973-08-01 SU SU731945967A patent/SU646915A3/ru active
- 1973-08-01 HU HUEE2163A patent/HU167266B/hu unknown
- 1973-08-01 PL PL1973164439A patent/PL87381B1/pl unknown
- 1973-08-01 DK DK422773A patent/DK131868C/da not_active IP Right Cessation
- 1973-08-01 MX MX737933U patent/MX4544E/es unknown
- 1973-08-01 DD DD172669A patent/DD107461A5/xx unknown
- 1973-08-01 NO NO3084/73A patent/NO137941C/no unknown
- 1973-08-02 NL NL737310706A patent/NL152864B/xx not_active IP Right Cessation
- 1973-08-02 FI FI732438A patent/FI52466C/fi active
- 1973-08-02 JP JP48086440A patent/JPS5235726B2/ja not_active Expired
- 1973-08-02 CH CH1125173A patent/CH592112A5/xx not_active IP Right Cessation
-
1980
- 1980-06-12 HK HK315/80A patent/HK31580A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES417377A1 (es) | Un procedimiento para preparar tri-ptoluensulfonato de s- adenosil-l-metionina. | |
| HUP9801175A2 (hu) | Helyileg alkalmazható gyógyszerkészítmény, eljárás előállítására és a készítmény alkalmazása | |
| KR870006074A (ko) | 고순도 아카르보스 및 그의 제조방법 | |
| ATE67667T1 (de) | Neue topische metronidazol-formulierungen. | |
| ATA21888A (de) | Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken | |
| JPS5699412A (en) | Rosemary aciddcontaining pharmaceutic product | |
| PH14013A (en) | Manufactured products for topical application to or consumption by the human body containing an ingredient capable of stimulating the cold receptors of the nervous system | |
| JPS56115793A (en) | Phosphonohydroxyacetic acid* its salt* their manufacture and drug thereof as active component | |
| IE45054L (en) | Veterinary composition | |
| PH13628A (en) | Manufactured products for topical application to or consumption by the human body containing an ingredient capable of stimulating the gold receptors of the nervous system | |
| FR2358893A1 (fr) | Composition antimicrobienne contenant des 1-imidazolyl-butane-2-ones ou -butane-2-ols halogenes | |
| Eaton et al. | Inhibition of influenza and mumps viruses in tissue culture by basic amino acids. | |
| NL167691C (nl) | Werkwijze ter bereiding of vervaardiging van therapeutische preparaten ter verzachting en opheffing van pijnen van verschillende oorsprong, alsmede ter behandeling van reumatische, artritische en andere ontstekingsziekten, waarbij men een werkzame stof in een voor therapeutische toepassing geschikte toedieningsvorm brengt, alsmede een werkwijze voor het bereiden van imidazoolverbindingen en de farmaceutisch aanvaardbare additiezouten daarvan, geschikt voor toepassing bij deze werkwijze. | |
| GB977214A (en) | Chemical compounds | |
| GB1464467A (en) | Pharmaceutical composition for the treatment of coronary | |
| ES421854A1 (es) | Procedimiento para la preparacion de cloruro de lisino-cal-cio. | |
| FR2374036A1 (fr) | Compositions pharmaceutiques contenant de la 3-phenoxypyridine | |
| SU60090A1 (ru) | Способ приготовлени лечебного препарата, содержащего уротропин и иод | |
| IL34468A0 (en) | Acid addition salts of indenopyridine derivatives,their preparation and pharmaceutical compositions containing them | |
| SU573158A1 (ru) | Препарат дл лечени диспепсии тел т | |
| US3904765A (en) | Process for controlling lamellar dystrophy of fingernails | |
| GB903162A (en) | Kanamycin 3-phenyl salicylate and therapeutic compositions containing it | |
| GB1431709A (en) | Lysozyme derivatives | |
| GB1018134A (en) | Pharmaceutical compositions comprising salts of d-(í¬)-3-phosphoglyceric acid | |
| GB858455A (en) | Piperazine preparations for treatment of worm infections |